SCHEMBL19662769

SCHEMBL19662769

Cc1cccc(C(=O)Nc2ccc3cnn(C)c3c2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.61
▸ NPC1 O15118 4/20 0.61
▸ RAB9A P51151 4/20 0.61
▸ MEN1 O00255 4/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ KCNK3 O14649 6/20 0.58
▸ KCNK9 Q9NPC2 5/20 0.58
▸ KCNH2 Q12809 1/20 0.58
▸ MAOB P27338 3/20 0.55
▸ MAOA P21397 2/20 0.55
▸ ACHE P22303 1/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ TP53 P04637 2/20 0.54
▸ POLB P06746 1/20 0.54
▸ NT5E P21589 1/20 0.53
▸ FFAR1 O14842 1/20 0.52
▸ GLA P06280 1/20 0.52
▸ MAPK10 P53779 1/20 0.50
▸ BRAF P15056 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19662760 0.90 NPC1 (0.64) KMT2ANPC1RAB9AMEN1L3MBTL1
SCHEMBL19662795 0.87 MAOB (0.54) KMT2ANPC1RAB9AMEN1L3MBTL1
SCHEMBL21237216 0.85 HDAC8 (0.55) NPC1RAB9AKCNK3KCNK9MAOB
SCHEMBL4898390 0.80 TRPV1 (0.52) NPC1RAB9AMAOBMAOAACHE
SCHEMBL30006626 0.77 MAPT (0.53) KMT2ANPC1RAB9AMEN1MAOB
SCHEMBL29510910 0.77 NPC1 (0.78) KMT2ANPC1RAB9AMEN1KCNK3
SCHEMBL30323212 0.77 GRM4 (0.54) NPC1RAB9ATP53
SCHEMBL20524569 0.77 GRM4 (0.54) NPC1RAB9ATP53
SCHEMBL25591508 0.76 KDR (0.49) KMT2ANPC1RAB9AMEN1L3MBTL1
SCHEMBL1168044 0.76 ELANE (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 — — EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 — — WO disclosed
Send feedback